Drug Pipeline

Vortioxetine Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
4
Recruiting
1
Phase 3
4
Top Sponsors
Active Studies by Phase
Phase 4
1
Phase 3
1
Phase 2
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07266545 RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression… Unipolar Depression Recruiting
Phase 3
NCT07204314 A Study of Vortioxetine in Japanese Pediatric Patients With Major Depressive Disorder Major Depressive Disorder Recruiting
Phase 2
NCT06604520 Vortioxetine for the Treatment of Mood and Cognitive Symptoms in Frontotemporal Dementia Fronto-temporal Dementia Recruiting
Phase 1/2
NCT05814640 Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD) Depression Recruiting
Sponsors Running Vortioxetine Trials
First Affiliated Hospital of Chongqing Medical University (1) Johns Hopkins University (1) Takeda (1) Mayo Clinic (1)
Disease Areas
Depression (3) Dementia (1) Bipolar Disorder (1)
Get alerts when Vortioxetine trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free